These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9437199

  • 1. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC, Arborati M, Liapikos T, Clay KL, Murphy RC, Chapman MJ, Ninio E.
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [Abstract] [Full Text] [Related]

  • 2. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C, Lesnik P, Chapman MJ, Ninio E.
    Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
    [Abstract] [Full Text] [Related]

  • 3. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
    Tselepis AD, Dentan C, Karabina SA, Chapman MJ, Ninio E.
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
    [Abstract] [Full Text] [Related]

  • 4. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD.
    Atherosclerosis; 1996 Aug 23; 125(1):121-34. PubMed ID: 8831934
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E.
    Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA, Antonopoulou S, Karabina SP, Tsoukatos DC, Demopoulos CA, Tselepis AD.
    Biochim Biophys Acta; 1994 Jun 02; 1212(3):353-60. PubMed ID: 8199206
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 02; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 11. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
    Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM.
    J Biol Chem; 1989 Apr 05; 264(10):5331-4. PubMed ID: 2494162
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM, Tjoelker LW, McCormick SP, Vaitkus D, McIntyre TM, Gray PW, Young SG, Prescott SM.
    J Biol Chem; 1999 Mar 12; 274(11):7018-24. PubMed ID: 10066756
    [Abstract] [Full Text] [Related]

  • 14. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
    Marathe GK, Zimmerman GA, McIntyre TM.
    J Biol Chem; 2003 Feb 07; 278(6):3937-47. PubMed ID: 12466264
    [Abstract] [Full Text] [Related]

  • 15. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation.
    Androulakis N, Durand H, Ninio E, Tsoukatos DC.
    J Lipid Res; 2005 Sep 07; 46(9):1923-32. PubMed ID: 15995176
    [Abstract] [Full Text] [Related]

  • 16. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
    Schnitzer E, Pinchuk I, Fainaru M, Lichtenberg D, Yedgar S.
    Free Radic Biol Med; 1998 May 07; 24(7-8):1294-303. PubMed ID: 9626586
    [Abstract] [Full Text] [Related]

  • 17. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA.
    J Clin Invest; 1995 Feb 07; 95(2):774-82. PubMed ID: 7860760
    [Abstract] [Full Text] [Related]

  • 18. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    Stafforini DM, McIntyre TM, Carter ME, Prescott SM.
    J Biol Chem; 1987 Mar 25; 262(9):4215-22. PubMed ID: 3549727
    [Abstract] [Full Text] [Related]

  • 19. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
    Steinbrecher UP, Pritchard PH.
    J Lipid Res; 1989 Mar 25; 30(3):305-15. PubMed ID: 2723538
    [Abstract] [Full Text] [Related]

  • 20. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C, Sigari F, Segrado T, Hörkkö S, Hama S, Subbaiah PV, Miwa M, Navab M, Witztum JL, Reaven PD.
    Arterioscler Thromb Vasc Biol; 1999 Jun 25; 19(6):1437-46. PubMed ID: 10364074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.